Biofilm formation by Aspergillus fumigatus

Medical Mycology

Volumn 52, Issue 1, 2014, Pages 2-9

  Kaur, Savneet ^a   Singh, Shweta ^a  

^a GAUTAM BUDDHA UNIVERSITY   (India)

Author keywords

aspergilloma; Aspergillus fumigatus; biofilms; invasive pulmonary aspergillosis

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN; ITRACONAZOLE; POLYENE; PYRROLE; VORICONAZOLE;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ANTIFUNGAL RESISTANCE; ASPERGILLOMA; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BIOFILM; CELL WALL; HOST CELL; HUMAN; LUNG ASPERGILLOSIS; LUNG CAVITY; NONHUMAN; PHENOTYPE; REVIEW; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; VIRULENCE;

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BIOFILMS; DRUG RESISTANCE, FUNGAL; HUMANS; VIRULENCE;

EID: 84942087410     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2013.819592     Document Type: Review

References (59)

1. Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2003; 2: 114-122.
2. Chandra J, Kuhn DM, Mukherjee PK et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 2001; 183: 5385-5394.
3. Douglas LJ. Candida biofilms and their infections. Trends Mi-crobiol 2003; 11: 30-36.
4. Mullins J, Hutcheson P, Slavin RG. Aspergillus fumigatus spore concentrations in outside air: Cardiff and St.Louis compared. Clin Allergy 1984; 14: 251-254.
5. Ellis M, Richardson M, de Pauw B. Epidemiology. Hosp Med 2000; 61: 605-609.
6. Madan T, Kaur S, Saxena S et al. Role of collectins in innate immunity against aspergillosis. Med Mycol 2005; 43 (Suppl. 1): S155-163.
7. Park SJ, Mehrad B. Innate immunity to Aspergillus species. Clin Microbiol Rev 2009; 22: 535-551.
8. Filler SG, Sheppard DC. Fungal invasion of normally non-phagocytic host cells. PLoS Pathog 2006; 2: e129.
9. Beauvais A, Schmidt C, Guadagnini S et al. An extracellular matrix glues together the aerial-grown hyphae of Aspergillus fumigatus. Cell Microbiol 2007; 9: 1588-1600.
10. Mowat E, Butcher J, Lang S, Williams C, Ramage G. Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus. J Med Microbiol 2007; 56: 1205-1212.
11. Seidler MJ, Stefanie S, Müller FM. Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells. Antimicrob Agents Chemother 2008; 52: 4130-4136.
12. Singhal D, Baker L, Wormald PJ, Tan L. Aspergillus fumigatus biofilm on primary human sinonasal epithelial culture. Am J Rhino Allergy 2011; 25: 219-225.
13. Ramage G, Rajendran R, Gutierrez-Correa M, Jones B, Williams C. Aspergillus biofilms: clinical and industrial significance. FEMS Microbiol Lett 2011; 324: 89-97
14. Ramage G, Saville SP, Thomas DP, López-Ribot JL et al. Candida biofilms: an update. Eukaryot Cell 2004; 4: 633-638.
15. Loussert C, Schmtt C, Prevost MC, Balloy V, Fadel E. In vivo biofilm composition of Aspergillus fumigatus. Cell Microbio 2010; 12: 405-410.
16. Müller CF, Seider M, Beauvais A. Aspergillus fumigatus biofilms in the clinical setting. Medical Mycology 2011; 49: 96-100.
17. Paugam A, Baixench MT, Dufeu ND, Burgel PR, Sauter E et al. Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France. Med Mycol 2010; 48: 32-36.
18. Kraemer R, Delose'a N, Ballinari P, Gallati S, Crameri R. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am J Respir Crit Care Med 2006; 174: 1211-1220.
19. Mowat E, Rajendran R, Williams C, Mcculloch E, Jones B. Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation. FEMS Microbiol Lett 2010; 313: 96-102.
20. Pressler T, Frederiksen B, Skov M et al. Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection-a case control study. J Cyst Fibros 2006; 5: 9-15.
21. Kraemer R, Delose'a N, Ballinari P, Gallati S, Crameri R. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am J Respir Crit Care Med 2006; 174: 1211-1220.
22. Skov M, Pressler T, Jensen HE, Høiby N, Koch C. Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA). Thorax 1999; 54: 44-50.
23. Mowat E, Lang S, Williams C, McCulloch E, Jones B, Ramage G. Phase-dependent antifungal activity against Aspergillus fumiga-tus developing multicellular filamentous biofilms. J Antimicrob Chemother 2008; 62: 1281-1284.
24. Nett JE, Crawford K, Marchillo K, Andes DR. Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene. Antimicrob Agents Chemother 2010; 54: 3505-3508.
25. Rajendran R, Mowat E, McCulloch E et al. Azole resistance of Aspergillus fumigatus biofilms is partly associated with efflux pump activity. Antimicrob Agents Chemother 2011; 55: 2092-2097.
26. Mowat E, Williams C, Jones B, McChlery S, Ramage G. The characteristics of Aspergillus fumigatus mycetoma development: is this a biofilm? Med Mycol 2009; 47 (Suppl. 1): S120-126.
27. LaFleur MD, Kumamoto CA, Lewis K. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother 2006; 50: 3839-3846.
28. Latgé JP, Mouyna I, Tekaia F et al. Specific molecular features in the organization and biosynthesis of the cell wall of Aspergillus fumigatus. Med Mycol 2005; 43 (Suppl. 1): S15-22.
29. Gibbons JG, Beauvais A, Beau R et al. Global transcriptome changes underlying colony growth in the opportunistic human pathogen Aspergillus fumigatus. Eukaryot Cell 2012; 11: 68-78.
30. Paris S, Debeaupuis JP, Crameri R et al. Conidial hydrophobins of Aspergillus fumigatus. Appl Environ Microbiol 2003; 69: 1581-1588.
31. Sheppard DC. Molecular mechanism of Aspergillus fumigatus adherence to host constituents. Curr Opin Microbiol 2011; 14: 375-379.
32. Levdansky E, Kashi O, Sharon H, Shadkchan Y, Osherov N. The Aspergillus fumigatus cspA gene encoding a repeat-rich cell wall protein is important for normal conidial cell wall architecture and interaction with host cells. Eukaryot Cell 2010; 9: 1403-1415.
33. Leidich SD, Drapp DA, Orlean P. A conditionally lethal yeast mutant blocked at the first step in glycosylphosphatidylinositol anchor synthesis. J Biol Chem 1994; 269: 10193-10196
34. Li H, Zhou H, Luo Y et al. Glycosylphosphatidylinositol (GPI) anchor is required in Aspergillus fumigatus for morphogenesis and virulence. Mol Microbiol 2007; 64: 1014-1027.
35. Watanabe NA, Miyazaki M, Horii T et al. E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis. Antimicrob Agents Chemother 2012; 56: 960-971.
36. Pfaller MA, Duncanson F, Messer SA et al. In vitro activity of a novel broad-spectrum antifungal, E1210, tested against As-pergillus spp. determined by CLSI and EUCAST broth microdilution methods. Antimicrob Agents Chemother 2011; 55: 5155-5158.
37. Verstrepen KJ, Klis FM. Flocculation, adhesion and biofilm formation in yeasts. Mol Microbiol 2006; 60: 5-15.
38. De Groot PW, Kraneveld EA, Yin QY. The cell wall of the human pathogen Candida glabrata: differential incorporation of novel adhesin-like wall proteins. Eukaryot Cell 2008; 7: 1951-1964.
39. Upadhyay SK, Mahajan L, Ramjee S et al. Identification and characterization of a laminin-binding protein of Aspergillus fu-migatus: extracellular thaumatin domain protein (AfCalAp). J Med Microbiol 2009; 58: 714-722.
40. Chai LY, Netea MG, Sugui J et al. Aspergillus fumigatus coni-dial melanin modulates host cytokine response. Immunobiology 2010; 215: 915-920.
41. Tsai HF, Chang YC, Washburn RG, Wheeler MH, Kwon-Chung KJ. The developmentally regulated alb1 gene of Aspergillus fu-migatus: its role in modulation of conidial morphology and virulence. J Bacteriol 1998; 180: 3031-3038.
42. Thywißen A, Heinekamp T, Dahse HM et al. Conidial dihy-droxynaphthalene melanin of the human pathogenic fungus As-pergillus fumigatus interferes with the host endocytosis pathway. Front Microbiol 2011; 2: 96.
43. Heinekamp T, Thywißen A, Macheleidt J et al. Aspergillus fumi-gatus melanins: interference with the host endocytosis pathway and impact on virulence. Front Microbiol 2012; 3: 440.
44. Priegnitz BE, Wargenau A, Brandt U et al. The role of initial spore adhesion in pellet and biofilm formation in Aspergillus niger. Fungal Genet Biol 2012; 49: 30-38.
45. Flemming HC, Wingender J. The biofilm matrix. Nat Rev Mi-crobiol 2010; 8: 623-633.
46. Martins M, Uppuluri P, Thomas DP et al. Presence of extracellular DNA in the Candida albicans biofilm matrix and its contribution to biofilms. Mycopathologia 2010; 169: 323-331.
47. Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS. Extracellular DNA required for bacterial biofilm formation. Science 2002; 95: 1487.
48. Martins M, Henriques M, Lopez-Ribot JL, Oliveira R. Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms. Mycoses 2012; 55: 80-85.
49. Rajendran R, Williams C, Lappin DF et al. Extracellular DNA release acts as an antifungal resistance mechanism in mature Aspergillus fumigatus biofilms. Eukaryot Cell 2013; 12: 420-429.
50. Li X, Gao M, Han X et al. Disruption of the phospholipase D gene attenuates the virulence of Aspergillus fumigatus. Infect Immun 2012; 80: 429-40.
51. Lewis RE, Wiederhold NP, Chi J et al. Detection of gliotoxin in experimental and human aspergillosis. Infect Immun 2005; 73: 635-637.
52. Bruns S, Seidler M, Albrecht D et al. Functional genomic profiling of Aspergillus fumigatus biofilm reveals enhanced production of the mycotoxin gliotoxin. Proteomics 2010; 10: 3097-3107.
53. Tsunawaki S, Yoshida LS, Nishida S, Kobayashi T, Shimoyama T. Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidase. Infect Immun 2004; 72: 3373-3382.
54. Gravelat FN, Ejzykowicz DE, Chiang LY et al. Aspergillus fu-migatus MedA governs adherence, host cell interactions and virulence. Cell Microbiol 2010; 12: 473-488.
55. Clutterbuck AJ. A mutational analysis of conidial development in Aspergillus nidulans. Genetics 1969; 63: 317-327.
56. Nascimento AM, Goldman GH, Park S et al. Multiple resistance mechanisms among Aspergillus fumigatus mutants with highlevel resistance to itraconazole. Antimicrob Agents Chemother 2003; 47:1719-1726.
57. Slaven JW, Anderson MJ, Sanglard D et al. Increased expression of a novel Aspergillus fumigatus ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. Fungal Genet Biol 2002; 36: 199-206.
58. DaSilva Ferreira ME, Malavazi I, Savoldi M et al. Transcriptome analysis of Aspergillus fumigatus exposed to voriconazole. Curr Genet 2006; 50: 32-44.
59. Toyotome T, Yamaguchi M, Iwasaki A et al. Fetuin A, a serum component, promotes growth and biofilm formation by Aspergillus fumigatus. Int J Med Microbiol 2012; 302: 108-116.